期刊文献+

基底细胞样乳腺癌组织Apaf-1蛋白表达临床意义 被引量:4

Expression of Apaf-1 in basal-like breast carcinoma and its clinical significance
原文传递
导出
摘要 目的检测凋亡蛋白酶活化因子(Apaf-1)在基底细胞样乳腺癌(BLBC)中的表达,分析Apaf-1与BLBC临床病理特征的关系。方法采用免疫组化方法检测43例BLBC、57例non-BLBC和60例癌旁正常乳腺组织中Apaf-1蛋白的表达。结果免疫组化检测结果显示,在BLBC及non-BLBC中Apaf-1的表达的阳性率分别为23.26%和49.12%,明显低于癌旁正常乳腺组织的75.00%,差异均有统计学意义(P<0.05);Apaf-1的表达与患者年龄无关,与BLBC淋巴结转移、肿瘤大小及临床分期负相关(P<0.05)。结论 BLBC组织低表达Apaf-1,Apaf-1可能与BLBC的发生、发展密切相关。 Objective To detect and analyze the expression of Apaf-1 in basal-like breast cancer (BLBC) and correlation between Apaf-1 expression and clinicopathology features of BLBC . Methods The expression of Apaf-1 was detected in 43 cases of BLBC, 57 cases of non-BLBC and 60 cases of normal breast tissue by immunohistochemistry. Results The positive rate of Apaf-1 in BLBC and non-BLBC group were 23.62% and 49.12%, respectively, which were much lower than that in normal breast tissue (75.00%)(P〈0.05).The expression of Apaf-1 wasn't negatively correlated with age, but it was correlated with lymph nodes metastasis, tumor size and pTNM staging of BLBC(P〈0.05).Conclusion The expression level of Apaf-1 is lower and might be correlated with the carcinogenesis and development of BLBC.
出处 《中国热带医学》 CAS 2014年第9期1096-1098,共3页 China Tropical Medicine
关键词 乳腺肿瘤 基底细胞样乳腺癌 凋亡蛋白酶活化因子 Breast tumor Basal-like breast cancer (BLBC) Apaf-1
  • 相关文献

参考文献8

  • 1刘起胜.老年乳腺癌GSTπ、p53表达与淋巴结转移的相关性研究[J].中国煤炭工业医学杂志,2010,13(10):1457-1458. 被引量:4
  • 2Perou CM, Sorlie T, Eisen MB, et al. Molecular portraits of human breast tumors [J]. Nature,2000,406(6797):747-752.
  • 3郑天胜,李翔.线粒体凋亡通路的研究进展[J].医学综述,2013,19(18):3282-3285. 被引量:40
  • 4Marsden VS,Kanfmann T,O reiUy LA,et al,Apaf-1 and caspase-9 are required for cytokine withdrawal-induced apoptosis of mast cells but dispensable for their functional and clonogenic death [J]. Blood,2006, 107(5):1872-1877.
  • 5Ruiz-Vela A, Korsmeyer SJ. Proapoptotic histone H1.2 induces CASP-3 and -7 activation by forming a protein complex with CYT c, APAF-1 and CASP-9 [J]. FEBS Lett 2007,581:3422-3428.
  • 6Orzaez M, Mondragon L, Marzo I, et al. Conjugation of a novel Apaf-1 inhibitor to peptide-based cell-membrane transporters: effective meth- ods to improve inhibition of mitoehondria-mediated apoptosis [J]. Pep- tides, 2007, 28:958-968.
  • 7Ashraf QM,Mishra OP,Delivoria- of eX- pression of apoptotic protease activating factor-l(Apaf-1)in nuclear, mitochodrial and cytosolic fractions of the cerebral cortex of newborn piglets [J]. Neuresci Lett, 2007, 415:253-258.
  • 8Anichini A,Mortarini R,Sensi M,et al.APAF-1 signaling in human mel- anoma [J]. Cancer Lett, 2006, 238,168-179.

二级参考文献9

共引文献42

同被引文献35

  • 1徐菁,李士瑛,兰向昀.环氧化酶-2、c-erbB-2和Ki67在结直肠癌中表达及其临床意义[J].解剖学杂志,2005,28(3):287-289. 被引量:6
  • 2马业罡,娄毅,赵惠儒.非小细胞肺癌组织中Apaf-1基因表达及启动子区甲基化研究[J].中华肿瘤防治杂志,2006,13(2):116-119. 被引量:5
  • 3凌瑞,石梅,张聚良,陈江浩,王廷,王岭,姚青.乳腺癌新辅助化疗后细胞增殖与凋亡的变化及临床意义[J].中华肿瘤防治杂志,2007,14(14):1085-1087. 被引量:4
  • 4Kandel MJ, Stadler Z, Masciari S, et al. Basal cytokeratin and epider- mal growth factor receptor expression ale not predictive of BRCA1 mu- tation status in women with triple-negative breast cancers [J]. Am J Surg Pathol, 2009, 33 (7): 1093-1097.
  • 5Kuo YL, Chen DR, Chang TW. Clinicopahological features of triple-negative breast cancer in Taiwan Residents women [J]. Int J CIin Oncol, 2011, 16 (5): 500-505.
  • 6Patriarca C, Macchi R M, Marschner A K, et al. Epithelial cell adhe- sion molecule expression (CD326) in cancer: a short review[J]. Cancer Treat Rev, 2012,38(1) : 68-75.
  • 7Abd E1-Maqsoud N M, Abd Ebd EI-Rehim D M. Clinicopathologic im- plications of EpCAM and SOX2 expression in breast cancer [J]. Clin Breast Cancer, 2014, 14 (1): e1-9.
  • 8Goldhirseh A, Wood WC, Coates AS, el al. Strategies for subtypes- dealing with the diversity of breast cancer: highlights of the St. Gallen international expert consensus oil the primary therapy of early breast cancer 2011 [J]. Ann Oncol, 2011, 22 (8): 1736-1747.
  • 9Maier S, Wilbertz T, Braun M, et al. SOX2 amplification is a common event in squamous cell carcinomas of different organ sites [J]. Hum. Pathol, 2011, 42 (8): 1078 - 1088.
  • 10Chen Y, Shi L, Zhang L, et al. The molecular mechanism governing the oncogenic potential of SOX2 in breast cancer[J]. Biol. Chem., 2008, 283 (26): 17969 - 17978.

引证文献4

二级引证文献16

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部